Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 193

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis

Open access
Wu, Chong, Ning, Huiheng, Liu, Mingyu, Lin, Jie, Luo, Shufeng, Zhu, Wenjie, Xu, Jing, Wu, Wen-Chao, Liang, Jing, Shao, Chun-Kui, Ren, Jiaqi, Wei, Bin, Cui, Jun, Chen, Min-Shan, Zheng, Limin·2018·Journal of Clinical Investigation

Abstract

Cancer progression is associated with alterations of intra- and extramedullary hematopoiesis to support a systemic tumor-promoting myeloid response. However, the functional specialty, mechanism, and clinical relevance of extramedullary hematopoiesis (EMH) remain unclear. Here, we showed that the heightened splenic myelopoiesis in tumor-bearing hosts was not only characterized by the accumulation of myeloid precursors, but also associated with profound functional alterations of splenic early hematopoietic stem/progenitor cells (HSPCs). With the distinct capability to produce and respond to granulocyte-macrophage CSF (GM-CSF), these splenic HSPCs were "primed" and committed to generating immunosuppressive myeloid cells. Mechanistically, the CCL2/CCR2 axis-dependent recruitment and the subsequent local education by the splenic stroma were critical for eliciting this splenic HSPC response. Selective abrogation of this splenic EMH was sufficient to synergistically enhance the therapeutic efficacy of immune checkpoint blockade. Clinically, patients with different types of solid tumors exhibited increased splenic HSPC levels associated with poor survival. These findings reveal a unique and important role of splenic hematopoiesis in tumor-associated myelopoiesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci97973

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 193

Metadata

Authors
Wu, C., Ning, H., Liu, M., Lin, J., Luo, S., Zhu, W., Xu, J., Wu, W.-C., Liang, J., Shao, C.-K., Ren, J., Wei, B., Cui, J., Chen, M.-S., & Zheng, L.
Venue
Journal of Clinical Investigation
Published
2018-07-09
Volume
128
Issue
8
Pages
3425-3438
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2803199141
Cited by
193
References
13
FWCI
5.49
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis. https://app.cochat.ai/papers/10.1172/jci97973
The paper
Wu, C., Ning, H., Liu, M., Lin, J., Luo, S., Zhu, W., Xu, J., Wu, W.-C., Liang, J., Shao, C.-K., Ren, J., Wei, B., Cui, J., Chen, M.-S., & Zheng, L. (2018). Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis. Journal of Clinical Investigation. https://doi.org/10.1172/jci97973

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.